These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4554794)

  • 21. [A morphological evaluation of the harmlessness of noninvasive recombinant Shigella strains].
    Polotskiĭ IuE; Efremov VE; Bondarenko VM; Nastichkin IA; Belov AG; Kan IM; Smirnova GV; Romanova IuM; Kapustina AZ; Lavrenchuk MS
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):57-63. PubMed ID: 8067094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions.
    Bedford L; Fonseka S; Boren T; Ranallo RT; Suvarnapunya AE; Lee JE; Barnoy S; Venkatesan MM
    Gut Microbes; 2011; 2(4):244-51. PubMed ID: 21983066
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.
    Kowalewska D; Mulczyk M
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143
    [No Abstract]   [Full Text] [Related]  

  • 24. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. I. IMMUNE PHENOMENON AND ANTIBODY FORMATION.
    LIN FC; YANG TL; YEH SH
    Chin Med J; 1964 Jul; 83():454-62. PubMed ID: 14191218
    [No Abstract]   [Full Text] [Related]  

  • 25. [A study on cross immunity in Shigellae following local immunisation with living non-infectious agents].
    Istrati G; Meitert T; Ciufecu C; Sulea I
    Zentralbl Bakteriol Orig; 1970; 215(1):73-6. PubMed ID: 4922615
    [No Abstract]   [Full Text] [Related]  

  • 26. Virulence of Shigella strains isolated from dysenteric patients and symptomless carriers.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1968; 15(4):361-7. PubMed ID: 4892331
    [No Abstract]   [Full Text] [Related]  

  • 27. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.
    Linde K; Dentchev V; Bondarenko V; Marinova S; Randhagen B; Bratoyeva M; Tsvetanov Y; Romanova Y
    Vaccine; 1990 Feb; 8(1):25-9. PubMed ID: 2180230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the transfer of F1 plasmids of various lengths on Shigella sonnei virulence].
    Nastichkin IA; Lycheva TA; Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):60-3. PubMed ID: 6356729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'O'-antigens are essential virulence factors of Shigella sonnei and Shigella dysenteriae 1.
    Binns MM; Vaughan S; Timmis KN
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):197-205. PubMed ID: 2413650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV; Borisov VA
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory safety testing of live dysentery vaccine strains (author's transl)].
    Lesniak SV; Levenbuk IS; Fedotova Y; Belaya M; Yu A; Sergeev VV; Jikidze EK; Kavtaradze KN; Elkina SL
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):87-97. PubMed ID: 4216254
    [No Abstract]   [Full Text] [Related]  

  • 32. [L-forms of the dysentery bacteria in models of Shigella and non-Shigella infections].
    Fedorova ZF; Krotkova MR; Ivashchenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):5-6. PubMed ID: 8079561
    [No Abstract]   [Full Text] [Related]  

  • 33. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms].
    Borisova EV
    Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasmid profile types of virulent and avirulent strains of phase-I Shigella sonnei and their rough phase-II and R-form variants].
    Nastichkin IA; Romanova IuM; Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):14-8. PubMed ID: 2455394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of autoimmune changes in white mice as a method of studying the biological properties of Shigella sonnei].
    Paltyshev IP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Dec; (12):38-43. PubMed ID: 766519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic relationship among virulent enteroinvasive Escherichia coli, Shigella flexneri, and Shigella sonnei detected by ELISA.
    Pál T; Pácsa S; Emödy L; Vörös S
    Lancet; 1983 Jul; 2(8341):102. PubMed ID: 6134933
    [No Abstract]   [Full Text] [Related]  

  • 37. [Activity of various enzyme systems of Shigella sonnei].
    Bernasovs'ka EP; Vasiurenko ZP; Illarionova RP; Lisenko ZA
    Mikrobiol Zh; 1975; 37(3):333-6. PubMed ID: 765696
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 39. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei].
    Borisova EV; Borisov VA
    Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suppression of the immune response by Shigella in experimental influenza infection in mice].
    Frolov AF; Borisov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):104-8. PubMed ID: 6760625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.